The Nicotinamide Mononucleotide (NMN) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nicotinamide Mononucleotide (NMN) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Nicotinamide Mononucleotide (NMN) market can be split based on product types, major applications, and important countries as follows:
Key players in the global Nicotinamide Mononucleotide (NMN) market covered in Chapter 12:
Suzhou Pilot Biological Technology Co., Ltd.
Hangzhou Weitai Biological Pharmaceutical Co., Ltd.
Zhejiang Jiahua Chemical Co., Ltd.
Shenzhen Ejion Biotechnologgy
Suzhou Mailun Biotechnology Co., Ltd.
Hangzhou Zhiju Biotechnology Co., Ltd.
In Chapter 4 and 14.1, on the basis of types, the Nicotinamide Mononucleotide (NMN) market from 2015 to 2025 is primarily split into:
Pharm Grade
Food Grade
Others
In Chapter 5 and 14.2, on the basis of applications, the Nicotinamide Mononucleotide (NMN) market from 2015 to 2025 covers:
Dietary Supplements
Pharmaceutical
Food & Beverages
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Nicotinamide Mononucleotide (NMN) Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Nicotinamide Mononucleotide (NMN)
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Nicotinamide Mononucleotide (NMN) industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Nicotinamide Mononucleotide (NMN) Market Size, 2015 - 2020
2.1.2 Global Nicotinamide Mononucleotide (NMN) Market Size by Type, 2015 - 2020
2.1.3 Global Nicotinamide Mononucleotide (NMN) Market Size by Application, 2015 - 2020
2.1.4 Global Nicotinamide Mononucleotide (NMN) Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Nicotinamide Mononucleotide (NMN) Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Nicotinamide Mononucleotide (NMN) Analysis
3.2 Major Players of Nicotinamide Mononucleotide (NMN)
3.3 Nicotinamide Mononucleotide (NMN) Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Nicotinamide Mononucleotide (NMN)
3.3.3 Labor Cost of Nicotinamide Mononucleotide (NMN)
3.4 Market Distributors of Nicotinamide Mononucleotide (NMN)
3.5 Major Downstream Buyers of Nicotinamide Mononucleotide (NMN) Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Nicotinamide Mononucleotide (NMN) Market, by Type
4.1 Global Nicotinamide Mononucleotide (NMN) Value and Market Share by Type (2015-2020)
4.2 Global Nicotinamide Mononucleotide (NMN) Production and Market Share by Type (2015-2020)
4.3 Global Nicotinamide Mononucleotide (NMN) Value and Growth Rate by Type (2015-2020)
4.3.1 Global Nicotinamide Mononucleotide (NMN) Value and Growth Rate of Pharm Grade
4.3.2 Global Nicotinamide Mononucleotide (NMN) Value and Growth Rate of Food Grade
4.3.3 Global Nicotinamide Mononucleotide (NMN) Value and Growth Rate of Others
4.4 Global Nicotinamide Mononucleotide (NMN) Price Analysis by Type (2015-2020)
5 Nicotinamide Mononucleotide (NMN) Market, by Application
5.1 Downstream Market Overview
5.2 Global Nicotinamide Mononucleotide (NMN) Consumption and Market Share by Application (2015-2020)
5.3 Global Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate of Dietary Supplements (2015-2020)
5.3.2 Global Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate of Pharmaceutical (2015-2020)
5.3.3 Global Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate of Food & Beverages (2015-2020)
5.3.4 Global Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate of Others (2015-2020)
6 Global Nicotinamide Mononucleotide (NMN) Market Analysis by Regions
6.1 Global Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Regions
6.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Regions (2015-2020)
6.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Regions (2015-2020)
6.2 North America Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.3 Europe Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.6 South America Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7 North America Nicotinamide Mononucleotide (NMN) Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Countries
7.2.1 North America Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020)
7.2.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020)
7.3 United States Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.4 Canada Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.5 Mexico Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8 Europe Nicotinamide Mononucleotide (NMN) Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Countries
8.2.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020)
8.2.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020)
8.3 Germany Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.4 UK Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.5 France Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.6 Italy Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.7 Spain Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.8 Russia Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9 Asia Pacific Nicotinamide Mononucleotide (NMN) Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020)
9.2.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020)
9.3 China Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.4 Japan Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.5 South Korea Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.6 India Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.8 Australia Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10.4 UAE Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10.5 Egypt Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10.6 Nigeria Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10.7 South Africa Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
11 South America Nicotinamide Mononucleotide (NMN) Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Countries
11.2.1 South America Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020)
11.2.2 South America Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020)
11.3 Brazil Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
11.4 Argentina Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
11.5 Columbia Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
11.6 Chile Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Suzhou Pilot Biological Technology Co., Ltd.
12.1.1 Suzhou Pilot Biological Technology Co., Ltd. Basic Information
12.1.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.1.3 Suzhou Pilot Biological Technology Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.2 Hangzhou Weitai Biological Pharmaceutical Co., Ltd.
12.2.1 Hangzhou Weitai Biological Pharmaceutical Co., Ltd. Basic Information
12.2.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.2.3 Hangzhou Weitai Biological Pharmaceutical Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.3 Zhejiang Jiahua Chemical Co., Ltd.
12.3.1 Zhejiang Jiahua Chemical Co., Ltd. Basic Information
12.3.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.3.3 Zhejiang Jiahua Chemical Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.4 Shenzhen Ejion Biotechnologgy
12.4.1 Shenzhen Ejion Biotechnologgy Basic Information
12.4.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.4.3 Shenzhen Ejion Biotechnologgy Production, Value, Price, Gross Margin 2015-2020
12.5 Suzhou Mailun Biotechnology Co., Ltd.
12.5.1 Suzhou Mailun Biotechnology Co., Ltd. Basic Information
12.5.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.5.3 Suzhou Mailun Biotechnology Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.6 Hangzhou Zhiju Biotechnology Co., Ltd.
12.6.1 Hangzhou Zhiju Biotechnology Co., Ltd. Basic Information
12.6.2 Nicotinamide Mononucleotide (NMN) Product Introduction
12.6.3 Hangzhou Zhiju Biotechnology Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Nicotinamide Mononucleotide (NMN) Market Forecast
14.1 Global Nicotinamide Mononucleotide (NMN) Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Pharm Grade Market Value and Volume Forecast (2020-2025)
14.1.2 Food Grade Market Value and Volume Forecast (2020-2025)
14.1.3 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Nicotinamide Mononucleotide (NMN) Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Dietary Supplements Market Value and Volume Forecast (2020-2025)
14.2.2 Pharmaceutical Market Value and Volume Forecast (2020-2025)
14.2.3 Food & Beverages Market Value and Volume Forecast (2020-2025)
14.2.4 Others Market Value and Volume Forecast (2020-2025)
14.3 Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
